Effects of denosumab on bone mineral density and bone turnover markers in rheumatoid arthritis patients switching from bisphosphonates

To compare the efficacy of 12-month denosumab treatment on bone mineral density (BMD) and bone turnover markers (BTMs) between treatment-na ïve osteoporosis patients with rheumatoid arthritis (RA) and those wit...

Source: Journal of Experimental Orthopaedics - October 29, 2019 Category: Orthopaedics Authors: Tetsuya Kaneko, Koichi Okamura, Yukio Yonemoto, Chisa Okura, Takahito Suto, Masahiro Tachibana, Hideo Sakane, Makoto Inoue and Hirotaka Chikuda Tags: Research Source Type: research